The infant exposed to opioids in utero frequently presents a challenge to the neonatal care provider in the assessment and treatment of symptoms of Neonatal Abstinence Syndrome (NAS) after birth. This review is intended to provide the healthcare professional with a brief review of current evidence and practical guidelines for optimal evaluation and pharmacologic management of the opioid-exposed newborn.
- Neonatal abstinence syndrome
- Substance abuse
ASJC Scopus subject areas
- Pharmacology (medical)
- Anesthesiology and Pain Medicine